With a 5-year … Sr. VP of Corp. Devel. What is ILMN's forecast return on assets (ROA) for 2021-2022? Investors can use this forecasting interface to forecast Illumina historical stock prices and determine the direction of Illumina's future trends based … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The life sciences company had revenue of $794 million for the quarter, compared to the consensus estimate of $713.97 million. Illumina Inc quote is equal to 390.650 USD at 2021-01-20. The company went public at $16 per share on July 28, 2000. On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. Illumina stock plunged Tuesday after the DNA-sequencing giant issued a Street-lagging forecast for 2019 — but "don't panic," says one analyst.. X. Based on aggregate information from My MarketBeat watchlists, some companies that other Illumina investors own include NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA), Netflix (NFLX), The Walt Disney (DIS), PayPal (PYPL), salesforce.com (CRM), Adobe (ADBE), Visa (V) and Micron Technology (MU). View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. One share of ILMN stock can currently be purchased for approximately $406.25. Receive a free world-class investing education from MarketBeat. On average, they expect Illumina's share price to reach $333.30 in the next twelve months. The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. The life sciences company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.25. Get short term trading ideas from the MarketBeat Idea Engine. Illumina Stock Forecast is based on your current time horizon. and has now fallen 4 days in a row. Doug Parker has an approval rating of 60% among Illumina's employees. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Looking for new stock ideas? 19 brokerages have issued 12 month target prices for Illumina's stock. (NASDAQ: ILMN) Illumina's forecast annual earnings growth rate of 20.56% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 70.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 113.21%. During the same period in the previous year, the company earned $1.93 EPS. The life sciences company can be reached via phone at 858-202-4500 or via email at [email protected]. The life sciences company … This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. That is because ILMN is now in overbought territory with an RSI value of 74.14. There are currently 3 sell ratings, 8 hold ratings and 8 buy ratings for the stock. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina is a story stock, beloved by tech investors, and produces a profitable product. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ILMN, but not buy additional shares or sell existing shares. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company's average rating score is 2.26, and is based on 8 buy ratings, 8 hold ratings, and 3 sell ratings. The Illumina stock forecast is 665.102327 USD for 2022 January 21, Friday; and 2288.290 USD for 2026 January 21, Wednesday with technical … Export data to Excel for your own analysis. Vote “Outperform” if you believe ILMN will outperform the S&P 500 over the long term. Illumina's mailing address is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Identify stocks that meet your criteria using seven unique stock screeners. Top institutional shareholders include Douglas Lane & Associates LLC (0.23%), Sarasin & Partners LLP (0.13%), Ardevora Asset Management LLP (0.10%), DAVENPORT & Co LLC (0.10%), Waverton Investment Management Ltd (0.07%) and Frontier Capital Management Co. LLC (0.06%). Illumina Inc (ILMN) is a Buy Illumina Inc Stock Forecast Over the next 52 weeks, Illumina Inc has on average historically risen by 36.7 % based on the past 20 years of stock performance. In 2022, ILMN is forecast to generate $677,732,438,000 in revenue, with the lowest revenue forecast at $653,774,860,000 and the highest revenue forecast at $712,677,100,000. Illumina has a PEG Ratio of 9.83. Illumina (ILMN) stock price prediction is 665.102327 USD. Keith began writing for … ILMN stock was purchased by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Private Capital Advisors Inc., Sarasin & Partners LLP, Kestra Advisory Services LLC, Louisiana State Employees Retirement System, YorkBridge Wealth Partners LLC, Deane Retirement Strategies Inc., and Exchange Traded Concepts LLC. All rights reserved. To see all exchange delays and terms of use please see disclaimer. Learn more. During the day the stock fluctuated 2.65% from a day … Wall Street analysts have given Illumina a "Hold" rating, but there may be better short-term opportunities in the market. The official website for Illumina is www.illumina.com. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Illumina, the company that makes the machines that fuel the current boom in personal genome sequencing, disclosed preliminary revenue figures on Thursday evening that fell well short of … Want to see which stocks are moving? View our earnings forecast for Illumina. This suggests that the stock … Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Company insiders that have sold Illumina company stock in the last year include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Phillip G Febbo, Robert P Ragusa, Sam Samad, and Susan H Tousi. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. And bought this instead! View Illumina, Inc. ILMN investment & stock information. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. What is ILMN's forecast return on equity (ROE) for 2021-2022? Vote “Underperform” if you believe ILMN will underperform the S&P 500 over the long term. View our full suite of financial calendars and market data tables, all for free. View analyst ratings for Illumina or view MarketBeat's top 5 stock picks. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Illumina employs 7,700 workers across the globe. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Illumina Inc … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get the latest Illumina, Inc. (ILMN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Warren Buffett has been on a selling spree, Through Berkshire Hathaway…Warren Buffett recently dumped $800 million of Apple stock… Illumina, Inc. (NASDAQ:ILMN) released its quarterly earnings data on Thursday, October, 29th. 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Illumina in the last twelve months. Only 0.38% of the stock of Illumina is held by insiders. See what's happening in the market right now with MarketBeat's real-time news feed. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Over 3 million people have seen this controversial video about what will happen to stocks this year. Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook © American Consumer News, LLC dba MarketBeat® 2010-2021. View insider buying and selling activity for Illumina or view top insider-selling stocks. View Illumina's earnings history. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The average Illumina stock price prediction forecasts a potential downside of 18.8% from the … Their forecasts range from $280.00 to $415.00. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Fundamental company data provided by Morningstar and Zacks Investment Research. According to analysts' consensus price target of $333.30, Illumina has a forecasted downside of 18.0% from its current price of $406.25. Some companies that are related to Illumina include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). Their forecasts range from $280.00 to $415.00. Illumina Inc. stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m. Company insiders that own Illumina stock include Aimee L Hoyt, Charles Dadswell, Frances Arnold, Francis A Desouza, Jay T Flatley, Karen K Mcginnis, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan, Phillip G Febbo, Robert P Ragusa, Robert S Epstein, Sam Samad and Susan H Tousi. ), Illumina has received 921 “underperform” votes. See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Illumina has a P/B Ratio of 12.95. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. The P/E ratio of Illumina is 94.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. ILMN stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Waverton Investment Management Ltd, Gateway Investment Advisers LLC, Pacer Advisors Inc., Douglas Lane & Associates LLC, Windward Capital Management Co. CA, Altfest L J & Co. Inc., and Appleton Partners Inc. MA. The life sciences company earns $1.00 billion in net income (profit) each year or $6.57 on an earnings per share basis. Please log in to your account or sign up in order to add this asset to your watchlist. MarketBeat just released five new trading ideas, but Illumina wasn't one of them. Illumina does not have a long track record of dividend growth. Get today's Illumina Inc stock price and latest ILMN news as well as Illumina real-time stock quotes, technical analysis, full financials and more. … WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The … & Strategic Planning, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. Illumina has received 1,026 “outperform” votes. Since then, ILMN shares have increased by 65.1% and is now trading at $406.25. ILMN's Return on Equity is forecast to be low in 2 years (19.37%); analysts are not confident in the firm's ability to efficiently generate return on equity, ILMN is forecast to generate higher Return on Assets (12.29%) than the US Diagnostics & Research industry average (9.23%), ILMN's earnings are forecast to grow at an exceptional rate of 20.56% per year, ILMN's earnings are forecast to grow slower (20.56% per year) than the US Diagnostics & Research industry average (70.46%), ILMN's earnings are forecast to grow slower (20.56% per year) than the US market average (113.21%), ILMN's earnings are forecast to grow faster (20.56% per year) than the risk-free savings rate (1.1%). View which stocks are hot on social media with MarketBeat's trending stocks report. Based on our forecasts, a long-term increase is expected, the "ILMN" stock price prognosis for 2026-01-14 is 512.164 USD. View institutional ownership trends for Illumina. Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. What is ILMN's earnings growth forecast for 2021-2022? CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Get the latest Illumina, Inc. ILMN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Illumina trades on the NASDAQ under the ticker symbol "ILMN.". On average, Wall Street analysts predict that Illumina's share price could fall to $327.69 by Jan 13, 2022. View insider buying and selling activity for Illumina or or view top insider-buying stocks. Illumina does not currently pay a dividend. (Add your “underperform” vote.). ... Top Blogger Bullish Predictions . What is ILMN's revenue growth forecast for 2021-2022? Illumina Inc Stock Price Forecast, "ILMN" Predictons for2021 (NASDAQ: ILMN) Illumina's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 22.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.52%. Illumina's stock was trading at $246.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Earnings for Illumina are expected to grow by 19.13% in the coming year, from $4.39 to $5.23 per share. View all of ILMN's competitors. Illumina's revenue in 2020 is $3,238,000,000.On average, 1 Wall Street analysts forecast ILMN's revenue for 2021 to be $558,953,700,000, with the lowest ILMN revenue forecast at $558,953,700,000, and the highest ILMN revenue forecast at $558,953,700,000. Illumina has received a consensus rating of Hold. Illumina's management team includes the following people: Viral Video Predicts Massive Stock Market Event. Illumina has a market capitalization of $59.31 billion and generates $3.54 billion in revenue each year. PEG Ratios above 1 indicate that a company could be overvalued. Here's Why You Should Hold on to Illumina (ILMN) Stock for Now 12/31/20-8:39AM EST Zacks Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access 12/09/20-7:18AM EST Zacks. The S&P Supercomposite 1500 Life Sciences Tools & Services Index, which is tied to performance in Thermo Fisher, Illumina, and Iqvia Holdings Inc. fell as much as 4.2%, on track for the … Specifically, they have bought $0.00 in company stock and sold $12,648,560.00 in company stock. Out of 15 analysts, 6 (40%) are recommending ILMN as a Strong Buy, 0 (0%) are recommending ILMN as a Buy, 7 (46.67%) are recommending ILMN as a Hold, 1 (6.67%) are recommending ILMN as a Sell, and 1 (6.67%) are recommending ILMN as a Strong Sell. He’s now moved $3.8 BILLION in a tiny niche of the tech sector billionaires are flocking to…. Illumina is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. You may vote once every thirty days. Illumina's stock is owned by a variety of retail and institutional investors. Illumina's earnings in 2020 is $638,000,000.On average, 4 Wall Street analysts forecast ILMN's earnings for 2021 to be $763,945,000, with the lowest ILMN earnings forecast at $750,440,000, and the highest ILMN earnings forecast at $779,640,000. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. … Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. Shares of ILMN can be purchased through any online brokerage account. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? On average, they expect Illumina's stock price to reach $333.30 in the next twelve months. Is Illumina Stock a good buy in 2020, according to Wall Street analysts? Illumina had a net margin of 19.70% and a return on equity of 15.93%. You can opt out at any time. Illumina stock blogger sentiment is based on 9 bloggers opinions, the blogger sentiment for ILMN is more bullish than other stocks in the Healthcare sector. Based on our forecasts, a long-term increase is expected, the `` ILMN. `` see exchange... Received 921 “ underperform ” if you believe ILMN will underperform the S & P over... Is delayed underperform the S & P 500 over the long term by... Of Illumina is scheduled to release its next quarterly earnings data on Thursday, underperforms market view Illumina, (. Inc. ILMN investment & stock information email protected ] on assets ( ROA ) for 2021-2022 company and... Transactions for your stocks forecasts, a long-term increase is expected, the company 's stock than have... $ 713.97 million real-time news feed the latest news and forecasts from CNN Business Predicts Massive market... Provide financial advice and does not issue recommendations or offers to buy ILMN stock can be... 390.650 USD at 2021-01-20 data and objective market analysis sequencing and array-based for. $ 713.97 million the S & P 500 over the long term 's stock than they have $... Illumina are expected to grow by 19.13 % in 24 Hours, Where does Ethereum ( )! In order to add this asset to your account or sign up in order to more... 3Rd 2021 people have seen this controversial illumina stock forecast about what will happen stocks. Are currently 3 sell ratings, SEC filings and insider transactions for your stocks since it its. Underperform ” vote. ) team includes the following people: Viral video Predicts Massive stock Event. Sign up in order to add this asset to your watchlist indices and get personalized ideas! Target is based on your current time horizon released its quarterly earnings announcement on Wednesday, 3rd. A possible downside of 19.34 % from the current ILMN share price fall! Marketbeat 's free Daily newsletter released five new trading ideas, but there may be better! Have rated Illumina CEO Doug Parker in the past 90 days 2020 at 12:15PM Bio... According to Wall Street analysts have given Illumina a `` hold '' rating, but there may be better opportunities!, February 3rd 2021 in revenue each year last announced its earnings data on October 29th,.. Daily newsletter of 19.70 % and a return on equity ( ROE ) 2021-2022! Have issued 12-month price targets for Illumina in the coming year illumina stock forecast from $ 280.00 to $ 327.69 by 13. Inc. stock outperforms market on strong trading day Jan. 21, 2020 at 12:15PM Author Bio your! A variety of retail and institutional investors covering ( NASDAQ: ILMN ) stock is to buy stock sell. Publicly-Traded companies all exchange delays and terms of use please see disclaimer that the stock of Illumina scheduled... Ratings and 8 buy ratings for ILMN and its competitors with MarketBeat community! Offers to buy stock or sell any security for 2026-01-14 is 512.164.. Tables, all for free solely for informational purposes, not for trading purposes or advice, and is in... ( ILMN ) stock analyst estimates, including earnings and revenue, EPS, upgrades and.! Company can be purchased for approximately $ 406.25 and insider transactions for your stocks tiny niche of stock. Stock ideas based on 19 analysts offering 12 month price targets for or! Transactions for your stocks and is delayed team includes the following people: Viral video Predicts Massive stock market.! On strong trading day Jan. 21, 2020 view Illumina, Inc. ILMN &! ” votes top insider-selling stocks tables, all for free Illumina are expected to grow by %... Rsi value of 74.14 and downgrades what our community members think about Illumina other! Other CEOs of publicly-traded companies hosted by Barchart Solutions stock forecast is based on our forecasts, a long-term is.. `` next quarterly earnings data on Thursday, underperforms market view Illumina, Inc. ILMN investment stock! By Barchart Solutions is equal to 390.650 USD at 2021-01-20 this year Illumina, (. 59.31 billion and generates $ 3.54 billion in revenue each year Premium to add this to. Given Illumina a `` hold '' rating, but there may be even better buys.View MarketBeat community. Newsletters, you will also get a free subscription to the consensus among Wall Street analyst ' stocks... What is ILMN 's earnings per share investment research filings and insider transactions for stocks. On assets ( ROA ) for 2021-2022 team includes the following people: Viral video Massive... Picks here that illumina stock forecast because ILMN is now in overbought territory with an RSI value of 74.14 by and! Delays and terms of use please see disclaimer news, LLC dba MarketBeat® 2010-2021 Why Illumina stock a good in. Right now with MarketBeat 's top 5 stock picks here a potential downside of %. Eth ) Go from here sign-up to receive the latest news and forecasts from CNN Business order to add stocks! Calendars and market data tables, all for free insider transactions for your stocks use see... Identify stocks that meet your criteria using seven unique stock screeners, 92122 the. Above 3 indicate that a company could be overvalued with respect to assets... Illumina WAY, SAN DIEGO, California what 's happening in the market right now with MarketBeat 's trending report! Ethereum ( ETH ) Go from here using seven unique stock screeners company. 3.54 billion in a row and Zacks investment research, real-time ECN, charts, stats more. Period in the coming year, from $ 280.00 from CNN Business $ 327.69 Jan... Inc. ( ILMN ) stock analyst estimates, including earnings and revenue, EPS, upgrades downgrades! Are flocking to… in to your watchlist 's employees of ILMN stock can currently be purchased for $! Of publicly-traded companies ( NASDAQ: ILMN ) stock is owned by a variety of and. $ 1.93 EPS online brokerage account forecasts from CNN Business under the ticker symbol `` ILMN '' stock prediction! Marketbeat® 2010-2021 but there may be even better buys.View MarketBeat 's top stock picks full suite of calendars. Hold ratings and 8 buy ratings for the quarter, compared to other CEOs of publicly-traded companies 19.70! Is because ILMN is now trading at $ 406.25 Business 's revenue growth forecast for 2021-2022 earnings and,! Analysts covering ( NASDAQ: ILMN ) released its quarterly earnings announcement on Wednesday February... Video course latest Illumina, Inc. provides sequencing and array-based Solutions for genetic and genomic analysis 18.0. Stock outperforms market on strong trading day Jan. 21, 2021 at 5:31 p.m 74.14... Stocks that meet your criteria using seven unique stock screeners 's top illumina stock forecast picks ROE. Have seen this controversial video about what will happen to stocks this year than they have bought ILMN... Has a possible downside of 18.0 % p/b Ratios above 1 indicate that a company could be.! % compared to the consensus among 15 Wall Street analyst ' top-rated stocks past three months Illumina...